onc-392
Showing 1 - 3 of 3
Non Small Cell Lung Cancer Trial in Davis, Orlando, Columbus (ONC-392, Docetaxel)
Not yet recruiting
- Non Small Cell Lung Cancer
- ONC-392
- Docetaxel
-
Davis, California
- +2 more
Jan 5, 2023
Metastatic Castration-resistant Prostate Cancer Trial (ONC-392, lutetium Lu 177 vipivotide tetraxetan 7.4 GBq (200 mCi), IV
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- ONC-392
- lutetium Lu 177 vipivotide tetraxetan 7.4 GBq (200 mCi), IV infusion, Q6W for up to 6 doses.
- (no location specified)
Dec 27, 2022